ZOLMITRIPTAN

ZOLMITRIPTAN was reported 7251 times

ZOLMITRIPTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL HYPOPLASIA OF DEPRESSOR ANGULARIS ORIS MUSCLE 7 0.2593
1 VASCULAR MALFORMATION 45 0.2143
2 PARANASAL CYST 45 0.1852
3 TRIGEMINO-CARDIAC REFLEX 7 0.0864
4 POLYMENORRHAGIA 6 0.0759
5 FOETAL MOVEMENTS DECREASED 6 0.0588
6 MASTOIDITIS 54 0.0550
7 MENINGOENCEPHALITIS BACTERIAL 8 0.0541
8 MONOCYTE COUNT ABNORMAL 11 0.0495
9 SKIN CANDIDA 24 0.0460
10 MEDICATION OVERUSE HEADACHE 35 0.0409
11 PARAESTHESIA EAR 6 0.0408
12 PATIENT ISOLATION 8 0.0372
13 THUNDERCLAP HEADACHE 7 0.0267
14 POST PROCEDURAL OEDEMA 6 0.0259
15 MUSCLE MASS 11 0.0243
16 INTRACRANIAL TUMOUR HAEMORRHAGE 9 0.0233
17 MICROPHTHALMOS 6 0.0221
18 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 53 0.0199
19 URTICARIA CHRONIC 11 0.0196
20 CAROTID ARTERY DISSECTION 7 0.0164
21 SINONASAL OBSTRUCTION 6 0.0149
22 OTITIS MEDIA 47 0.0142
23 PRINZMETAL ANGINA 14 0.0141
24 UTERINE CYST 8 0.0141
25 ANTIBODY TEST POSITIVE 22 0.0132
26 CRANIOSYNOSTOSIS 11 0.0127
27 CLUSTER HEADACHE 17 0.0124
28 BURNS THIRD DEGREE 13 0.0123
29 DUST ALLERGY 12 0.0122
30 EUSTACHIAN TUBE DYSFUNCTION 7 0.0122
31 ANDROGEN DEFICIENCY 4 0.0114
32 HEMIANOPIA 11 0.0111
33 RENAL INFARCT 16 0.0110
34 VASOSPASM 10 0.0109
35 PHONOPHOBIA 5 0.0109
36 MIGRAINE 1034 0.0108
37 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 20 0.0101
38 LYMPHOCYTE COUNT ABNORMAL 11 0.0098
39 NASAL INFLAMMATION 10 0.0095
40 NASAL DISCHARGE DISCOLOURATION 13 0.0094
41 CORONARY ARTERY DISSECTION 8 0.0093
42 RESTING TREMOR 6 0.0093
43 BRONCHIAL OBSTRUCTION 13 0.0093
44 RENAL APLASIA 6 0.0085
45 ALLERGY TO METALS 5 0.0082
46 NASAL OEDEMA 14 0.0077
47 MUSCLE DISCOMFORT 6 0.0076
48 AURA 14 0.0075
49 SWOLLEN TONGUE 230 0.0074
50 BLOOD THYROID STIMULATING HORMONE NORMAL 6 0.0073
51 BLOOD IMMUNOGLOBULIN E INCREASED 16 0.0066
52 INFREQUENT BOWEL MOVEMENTS 16 0.0064
53 PULPITIS DENTAL 6 0.0064
54 SACROILIITIS 12 0.0064
55 PULMONARY HYPOPLASIA 5 0.0063
56 AORTIC VALVE DISEASE 10 0.0062
57 DACTYLITIS 6 0.0061
58 HYPERTENSIVE EMERGENCY 7 0.0059
59 BREAST ABSCESS 6 0.0059
60 HYPOSPADIAS 12 0.0058
61 OLIGOHYDRAMNIOS 19 0.0057
62 MITRAL VALVE DISEASE 10 0.0056
63 PANCREATIC MASS 6 0.0056
64 INTRACRANIAL VENOUS SINUS THROMBOSIS 6 0.0056
65 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 6 0.0055
66 EXPOSURE TO SARS-COV-2 9 0.0053
67 ANGIOEDEMA 233 0.0053
68 TUBERCULIN TEST POSITIVE 13 0.0051
69 NASAL ULCER 8 0.0050
70 FORCED EXPIRATORY VOLUME DECREASED 14 0.0049
71 BENIGN BREAST NEOPLASM 5 0.0049
72 TENSION HEADACHE 21 0.0049
73 BLOOD PRESSURE DIASTOLIC ABNORMAL 12 0.0047
74 BILIARY DYSKINESIA 8 0.0047
75 APPLICATION SITE WARMTH 6 0.0047
76 BLOOD PRESSURE SYSTOLIC ABNORMAL 11 0.0044
77 CORTISOL DECREASED 5 0.0044
78 TEMPERATURE INTOLERANCE 44 0.0043
79 INTRUSIVE THOUGHTS 5 0.0042
80 ARTERIOSPASM CORONARY 17 0.0042
81 CHOLECYSTITIS CHRONIC 28 0.0042
82 DYSPHONIA 244 0.0042
83 PRE-EXISTING CONDITION IMPROVED 26 0.0042
84 MIGRAINE WITH AURA 11 0.0040
85 EAR PRURITUS 14 0.0040
86 NEURITIS 6 0.0039
87 CEREBRAL VENOUS THROMBOSIS 7 0.0039
88 THERAPY PARTIAL RESPONDER 60 0.0038
89 ONYCHOLYSIS 6 0.0038
90 INTENTIONAL DRUG MISUSE 80 0.0038
91 DRUG INTOLERANCE 369 0.0038
92 ANALGESIC DRUG LEVEL INCREASED 6 0.0037
93 CYSTITIS NONINFECTIVE 5 0.0037
94 SKIN DEPIGMENTATION 5 0.0037
95 SWELLING FACE 237 0.0036
96 MAJOR DEPRESSION 26 0.0036
97 COLITIS ISCHAEMIC 24 0.0036
98 PULMONARY PAIN 10 0.0034
99 COMPLEX REGIONAL PAIN SYNDROME 5 0.0034
100 NEUTROPENIC SEPSIS 24 0.0034
101 LANGUAGE DISORDER 7 0.0032
102 BLOOD IMMUNOGLOBULIN G DECREASED 8 0.0032
103 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 177 0.0032
104 ENTHESOPATHY 5 0.0032
105 ANTICHOLINERGIC SYNDROME 5 0.0031
106 ANGLE CLOSURE GLAUCOMA 8 0.0031
107 FINE MOTOR SKILL DYSFUNCTION 9 0.0031
108 MONOPLEGIA 13 0.0030
109 HYPERCAPNIA 9 0.0030
110 BRAIN DEATH 9 0.0029
111 ACUTE SINUSITIS 5 0.0029
112 BREAST CYST 5 0.0028
113 DRUG ABUSER 17 0.0028
114 STRESS CARDIOMYOPATHY 16 0.0027
115 SPUTUM DISCOLOURED 25 0.0026
116 RECTAL CANCER 8 0.0026
117 CONVERSION DISORDER 5 0.0026
118 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
119 INTRACRANIAL PRESSURE INCREASED 14 0.0025
120 RHINITIS ALLERGIC 11 0.0025
121 MUSCLE TIGHTNESS 40 0.0025
122 SKIN ATROPHY 14 0.0024
123 SMALL FOR DATES BABY 12 0.0024
124 SENSATION OF HEAVINESS 9 0.0023
125 CATHETER SITE PAIN 6 0.0023
126 CRANIOCEREBRAL INJURY 7 0.0023
127 ENDOMETRIOSIS 11 0.0023
128 CERVICAL DYSPLASIA 5 0.0023
129 SEROTONIN SYNDROME 44 0.0023
130 ENDOMETRIAL CANCER 5 0.0023
131 TENDERNESS 23 0.0022
132 SUICIDAL BEHAVIOUR 9 0.0022
133 SINUS PAIN 5 0.0021
134 PSYCHOMOTOR RETARDATION 6 0.0021
135 SUSPECTED COVID-19 7 0.0021
136 UTERINE HAEMORRHAGE 9 0.0021
137 THROAT TIGHTNESS 57 0.0021
138 LYME DISEASE 7 0.0021
139 ANXIETY DISORDER 7 0.0021
140 HYPOMAGNESAEMIA 29 0.0021
141 RED BLOOD CELL SEDIMENTATION RATE INCREASED 23 0.0021
142 AUTONOMIC NERVOUS SYSTEM IMBALANCE 6 0.0021
143 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
144 JAUNDICE CHOLESTATIC 7 0.0020
145 ENURESIS 8 0.0020
146 FIBROMYALGIA 48 0.0020
147 ENDODONTIC PROCEDURE 5 0.0020
148 MENOPAUSE 5 0.0019
149 SLEEP APNOEA SYNDROME 37 0.0019
150 PRODUCT PACKAGING DIFFICULT TO OPEN 5 0.0019
151 HYPOMANIA 7 0.0019
152 GESTATIONAL DIABETES 9 0.0019
153 HYPERACUSIS 7 0.0019
154 FACIAL PARALYSIS 16 0.0019
155 ANIMAL BITE 5 0.0019
156 INTERVERTEBRAL DISC DISORDER 8 0.0019
157 VENTRICULAR HYPOKINESIA 6 0.0019
158 DYSPNOEA EXERTIONAL 70 0.0019
159 EAR DISCOMFORT 19 0.0018
160 ANORGASMIA 5 0.0018
161 THERAPEUTIC PRODUCT EFFECT VARIABLE 7 0.0018
162 EAR PAIN 35 0.0018
163 DISTURBANCE IN ATTENTION 97 0.0018
164 CORONARY ARTERY STENOSIS 9 0.0018
165 THERAPEUTIC RESPONSE DELAYED 5 0.0018
166 DRUG USE DISORDER 15 0.0018
167 SNEEZING 40 0.0018
168 VENTRICULAR SEPTAL DEFECT 10 0.0017
169 DEPRESSION SUICIDAL 6 0.0017
170 DRUG DOSE OMISSION 284 0.0017
171 PERIPHERAL VENOUS DISEASE 7 0.0017
172 HANGOVER 6 0.0017
173 NEONATAL RESPIRATORY DISTRESS SYNDROME 6 0.0017
174 ORAL HERPES 33 0.0017
175 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
176 PLEURISY 10 0.0017
177 BRAIN INJURY 16 0.0016
178 PHOTOPHOBIA 30 0.0016
179 BREAST TENDERNESS 12 0.0016
180 INFUSION SITE PRURITUS 5 0.0016
181 EXTRASYSTOLES 11 0.0016
182 FACIAL PAIN 14 0.0016
183 MOUTH ULCERATION 33 0.0016
184 JOINT RANGE OF MOTION DECREASED 21 0.0016
185 BIPOLAR DISORDER 17 0.0016
186 SEASONAL ALLERGY 22 0.0016
187 HYPERSENSITIVITY 287 0.0015
188 ANTINUCLEAR ANTIBODY POSITIVE 5 0.0015
189 VITAMIN D DEFICIENCY 15 0.0015
190 PARALYSIS 22 0.0015
191 THERAPEUTIC PRODUCT EFFECT DELAYED 7 0.0015
192 ABDOMINAL HERNIA 7 0.0015
193 HEADACHE 958 0.0015
194 NEPHROLITHIASIS 70 0.0015
195 VISUAL FIELD DEFECT 11 0.0015
196 LIGAMENT SPRAIN 15 0.0015
197 NYSTAGMUS 8 0.0015
198 UTERINE LEIOMYOMA 11 0.0015
199 VAGINAL INFECTION 7 0.0015
200 NAIL DISORDER 13 0.0015
201 VERTIGO 90 0.0015
202 RESPIRATORY RATE INCREASED 13 0.0015
203 PAROSMIA 11 0.0015
204 GALLBLADDER DISORDER 26 0.0015
205 APHAGIA 7 0.0015
206 DEAFNESS UNILATERAL 8 0.0015
207 SPINAL PAIN 17 0.0014
208 NERVOUS SYSTEM DISORDER 45 0.0014
209 ANKYLOSING SPONDYLITIS 19 0.0014
210 HORMONE LEVEL ABNORMAL 7 0.0014
211 ATRIAL SEPTAL DEFECT 12 0.0014
212 EMBOLIC STROKE 5 0.0014
213 OVARIAN CYST 14 0.0014
214 FRUSTRATION 5 0.0014
215 VISUAL DISTURBANCE 8 0.0014
216 HYSTERECTOMY 12 0.0014
217 TOOTH INJURY 6 0.0014
218 CAROTID ARTERY OCCLUSION 5 0.0014
219 GASTROINTESTINAL PAIN 15 0.0014
220 NECK PAIN 76 0.0014
221 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
222 IMPAIRED WORK ABILITY 29 0.0014
223 DISSEMINATED INTRAVASCULAR COAGULATION 19 0.0013
224 SINUS HEADACHE 8 0.0013
225 HYPERAESTHESIA 11 0.0013
226 ACUTE CORONARY SYNDROME 11 0.0013
227 IMPAIRED GASTRIC EMPTYING 18 0.0013
228 PHARYNGOLARYNGEAL PAIN 7 0.0013
229 CROHN'S DISEASE 9 0.0013
230 DISCOMFORT 80 0.0013
231 TONGUE OEDEMA 5 0.0013
232 INCREASED TENDENCY TO BRUISE 12 0.0013
233 THYROID MASS 5 0.0013
234 MENISCUS INJURY 8 0.0013
235 IRON DEFICIENCY ANAEMIA 12 0.0013
236 FAECALOMA 7 0.0013
237 ABDOMINAL ADHESIONS 4 0.0013
238 OESOPHAGEAL PAIN 5 0.0013
239 POLYDIPSIA 5 0.0013
240 RETINAL HAEMORRHAGE 9 0.0013
241 LOW TURNOVER OSTEOPATHY 5 0.0013
242 GALACTORRHOEA 8 0.0012
243 INFUSION SITE PAIN 16 0.0012
244 PERIPHERAL COLDNESS 17 0.0012
245 HIATUS HERNIA 16 0.0012
246 COELIAC DISEASE 12 0.0012
247 ORAL DISCOMFORT 17 0.0012
248 TINNITUS 56 0.0012
249 OPTIC NEURITIS 11 0.0012
250 NASAL CONGESTION 71 0.0012
251 NERVE COMPRESSION 11 0.0012
252 MUSCULOSKELETAL STIFFNESS 104 0.0012
253 COVID-19 PNEUMONIA 14 0.0012
254 CANDIDA INFECTION 20 0.0012
255 DYSLIPIDAEMIA 6 0.0012
256 THERAPEUTIC RESPONSE DECREASED 71 0.0012
257 SQUAMOUS CELL CARCINOMA 11 0.0012
258 ABORTION INDUCED 11 0.0012
259 VARICOSE VEIN 6 0.0012
260 POOR VENOUS ACCESS 12 0.0012
261 CHOLELITHIASIS 38 0.0012
262 PELVIC FRACTURE 9 0.0012
263 AUTOIMMUNE HEPATITIS 8 0.0011
264 PARTIAL SEIZURES 6 0.0011
265 AFFECTIVE DISORDER 9 0.0011
266 GASTROOESOPHAGEAL REFLUX DISEASE 92 0.0011
267 PARONYCHIA 5 0.0011
268 THERAPEUTIC RESPONSE UNEXPECTED 51 0.0011
269 PHARYNGEAL SWELLING 11 0.0011
270 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
271 PARAESTHESIA 176 0.0011
272 DRUG EXPOSURE DURING PREGNANCY 38 0.0011
273 SINUS CONGESTION 15 0.0011
274 PRODUCT TASTE ABNORMAL 15 0.0011
275 DECUBITUS ULCER 9 0.0011
276 ANAPHYLACTIC REACTION 61 0.0011
277 MOOD ALTERED 30 0.0011
278 RESTLESS LEGS SYNDROME 20 0.0011
279 DYSPHAGIA 104 0.0011
280 PALPITATIONS 128 0.0011
281 GRAND MAL CONVULSION 10 0.0011
282 EYELID PTOSIS 11 0.0011
283 HEMIPLEGIA 9 0.0011
284 FEELING DRUNK 8 0.0011
285 CHEST DISCOMFORT 110 0.0011
286 MUCOSAL INFLAMMATION 28 0.0011
287 POOR QUALITY SLEEP 23 0.0011
288 LIMB DISCOMFORT 33 0.0011
289 ISCHAEMIC STROKE 19 0.0011
290 CEREBRAL INFARCTION 26 0.0011
291 TOOTH INFECTION 14 0.0011
292 PRODUCT FORMULATION ISSUE 7 0.0011
293 APHASIA 32 0.0011
294 SPINAL COLUMN STENOSIS 5 0.0011
295 LIP SWELLING 35 0.0010
296 CHOLECYSTECTOMY 12 0.0010
297 DRY MOUTH 85 0.0010
298 POST-TRAUMATIC STRESS DISORDER 7 0.0010
299 PANIC ATTACK 38 0.0010
300 BREAST MASS 7 0.0010
301 FEELING COLD 29 0.0010
302 PARAESTHESIA ORAL 15 0.0010
303 RESPIRATORY TRACT INFECTION 27 0.0010
304 CONCUSSION 8 0.0010
305 ROAD TRAFFIC ACCIDENT 43 0.0010
306 SUICIDAL IDEATION 94 0.0010
307 MENINGIOMA 16 0.0010
308 SINUSITIS 105 0.0010
309 ACUTE HEPATIC FAILURE 14 0.0010
310 PANCREATIC DISORDER 5 0.0010
311 ACTIVITIES OF DAILY LIVING IMPAIRED 20 0.0010
312 NASAL DISCOMFORT 8 0.0010
313 WOUND INFECTION 11 0.0010
314 HYPERLIPIDAEMIA 12 0.0010
315 DEEP VEIN THROMBOSIS 65 0.0010
316 HYPERAMMONAEMIA 5 0.0010
317 HYPOKALAEMIA 46 0.0010
318 DENTAL CARIES 11 0.0010
319 SENSORY LOSS 8 0.0010
320 LYMPHADENOPATHY 35 0.0010
321 INGUINAL HERNIA 6 0.0010
322 SINUS TACHYCARDIA 14 0.0010
323 DYSARTHRIA 37 0.0010
324 DEPRESSION 223 0.0010
325 INITIAL INSOMNIA 10 0.0010
326 STATUS EPILEPTICUS 11 0.0010
327 CHOKING 19 0.0010
328 PHOTOSENSITIVITY REACTION 16 0.0010
329 IMPAIRED DRIVING ABILITY 11 0.0010
330 INSOMNIA 257 0.0010
331 MIDDLE INSOMNIA 18 0.0010
332 DRY EYE 48 0.0010
333 INJURY 67 0.0010
334 SENSITIVE SKIN 7 0.0009
335 MADAROSIS 11 0.0009
336 NEURALGIA 23 0.0009
337 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
338 VASCULITIS 11 0.0009
339 TREMOR 156 0.0009
340 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 45 0.0009
341 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
342 IRRITABLE BOWEL SYNDROME 20 0.0009
343 NIGHT SWEATS 30 0.0009
344 OVERWEIGHT 5 0.0009
345 MYALGIA 158 0.0009
346 HYPERPROLACTINAEMIA 6 0.0009
347 OSTEOARTHRITIS 39 0.0009
348 THINKING ABNORMAL 17 0.0009
349 TACHYCARDIA 81 0.0009
350 SARS-COV-2 TEST POSITIVE 12 0.0009
351 CHOKING SENSATION 5 0.0009
352 BLADDER DISORDER 9 0.0009
353 CONGENITAL ANOMALY 7 0.0009
354 INJECTION SITE INJURY 5 0.0009
355 SYSTEMIC LUPUS ERYTHEMATOSUS 32 0.0009
356 PRODUCTIVE COUGH 43 0.0009
357 NERVE INJURY 10 0.0009
358 STREPTOCOCCAL INFECTION 5 0.0009
359 THIRST 16 0.0009
360 MUSCLE SPASTICITY 11 0.0009
361 SMALL INTESTINAL OBSTRUCTION 11 0.0009
362 DEPRESSED MOOD 47 0.0009
363 HYPOTHERMIA 9 0.0009
364 DRY THROAT 9 0.0009
365 HEMIPARESIS 15 0.0009
366 LIVER FUNCTION TEST INCREASED 19 0.0009
367 PREMATURE LABOUR 5 0.0009
368 CHOLECYSTITIS ACUTE 5 0.0009
369 CIRCULATORY COLLAPSE 15 0.0009
370 INTENTIONAL PRODUCT MISUSE 77 0.0009
371 JOINT STIFFNESS 23 0.0009
372 BRAIN OEDEMA 11 0.0009
373 PARANOIA 15 0.0009
374 SOMNOLENCE 174 0.0009
375 PRESYNCOPE 21 0.0009
376 PETECHIAE 9 0.0009
377 DISABILITY 17 0.0009
378 FEAR 23 0.0009
379 BLOOD TEST ABNORMAL 12 0.0009
380 ANAPHYLACTIC SHOCK 22 0.0009
381 MANIA 14 0.0009
382 HAIR DISORDER 7 0.0008
383 RENAL PAIN 9 0.0008
384 LYMPHOPENIA 12 0.0008
385 PAIN IN JAW 24 0.0008
386 HAND FRACTURE 6 0.0008
387 THERMAL BURN 6 0.0008
388 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
389 ODYNOPHAGIA 5 0.0008
390 GASTRITIS 22 0.0008
391 CHOLESTASIS 16 0.0008
392 BODY TEMPERATURE INCREASED 17 0.0008
393 AFFECT LABILITY 8 0.0008
394 SENSATION OF FOREIGN BODY 7 0.0008
395 TYPE 1 DIABETES MELLITUS 5 0.0008
396 HYPERCHOLESTEROLAEMIA 8 0.0008
397 BACK INJURY 9 0.0008
398 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
399 EYE DISORDER 27 0.0008
400 METRORRHAGIA 14 0.0008
401 SPEECH DISORDER 43 0.0008
402 BLOOD PRESSURE SYSTOLIC INCREASED 16 0.0008
403 MOOD SWINGS 26 0.0008
404 HYPOTHYROIDISM 26 0.0008
405 MUSCULOSKELETAL DISCOMFORT 14 0.0008
406 LARYNGEAL OEDEMA 5 0.0008
407 PULMONARY EMBOLISM 77 0.0008
408 SENSORY DISTURBANCE 13 0.0008
409 GINGIVAL BLEEDING 11 0.0008
410 HYPOAESTHESIA 120 0.0008
411 TRANSIENT ISCHAEMIC ATTACK 27 0.0008
412 FOETAL EXPOSURE DURING PREGNANCY 65 0.0008
413 GASTRIC ULCER 15 0.0008
414 THERAPEUTIC RESPONSE SHORTENED 26 0.0008
415 DRUG ABUSE 65 0.0008
416 PHARYNGEAL OEDEMA 12 0.0008
417 CONSTIPATION 170 0.0008
418 APHTHOUS ULCER 6 0.0008
419 COGNITIVE DISORDER 36 0.0008
420 PELVIC PAIN 14 0.0008
421 DIPLOPIA 20 0.0008
422 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 5 0.0008
423 HEPATITIS ACUTE 5 0.0008
424 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
425 MULTIPLE ALLERGIES 6 0.0008
426 DEAFNESS 20 0.0008
427 FEELING ABNORMAL 183 0.0008
428 SOMNAMBULISM 5 0.0008
429 ANHEDONIA 20 0.0008
430 BEDRIDDEN 10 0.0008
431 SINUS DISORDER 15 0.0008
432 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
433 HOT FLUSH 57 0.0008
434 BURNING SENSATION 53 0.0008
435 CHOLECYSTITIS 9 0.0008
436 PRODUCT USE IN UNAPPROVED INDICATION 187 0.0008
437 DYSMENORRHOEA 10 0.0008
438 HYPERHIDROSIS 97 0.0008
439 BALANCE DISORDER 65 0.0008
440 WRIST FRACTURE 9 0.0008
441 BLOOD CHOLESTEROL INCREASED 35 0.0008
442 FEELING HOT 46 0.0007
443 ANAL FISSURE 4 0.0007
444 BRONCHITIS 55 0.0007
445 VOMITING 348 0.0007
446 DRUG INTERACTION 117 0.0007
447 JOINT SWELLING 89 0.0007
448 THERAPEUTIC PRODUCT EFFECT DECREASED 33 0.0007
449 ABNORMAL LOSS OF WEIGHT 5 0.0007
450 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
451 EYE MOVEMENT DISORDER 5 0.0007
452 PRODUCT SUBSTITUTION ISSUE 42 0.0007
453 RHINORRHOEA 47 0.0007
454 OSTEOPENIA 11 0.0007
455 ABORTION SPONTANEOUS 29 0.0007
456 HYPOTENSION 145 0.0007
457 URTICARIA 121 0.0007
458 FORMICATION 5 0.0007
459 AUTOIMMUNE DISORDER 7 0.0007
460 CHEST PAIN 133 0.0007
461 SKIN INFECTION 8 0.0007
462 HYPERTENSION 151 0.0007
463 NAUSEA 564 0.0007
464 VITREOUS FLOATERS 7 0.0007
465 NEUTROPHIL COUNT DECREASED 29 0.0007
466 APPLICATION SITE REACTION 5 0.0007
467 DELUSION 11 0.0007
468 HEART RATE IRREGULAR 16 0.0007
469 HEART RATE INCREASED 70 0.0007
470 PAIN 433 0.0007
471 HEPATITIS 18 0.0007
472 DERMATITIS CONTACT 8 0.0007
473 SCAR 12 0.0007
474 BRONCHOSPASM 10 0.0007
475 CONJUNCTIVITIS 13 0.0007
476 SYNCOPE 70 0.0007
477 ANURIA 6 0.0007
478 INJECTION SITE INDURATION 9 0.0007
479 MUSCLE TWITCHING 16 0.0007
480 VISUAL ACUITY REDUCED 23 0.0007
481 THROAT IRRITATION 31 0.0007
482 PRODUCT DOSE OMISSION 45 0.0007
483 NASOPHARYNGITIS 127 0.0007
484 MALAISE 302 0.0007
485 MUSCULAR WEAKNESS 78 0.0007
486 FOOT FRACTURE 13 0.0007
487 BLOOD CALCIUM INCREASED 6 0.0007
488 THROMBOSIS 55 0.0007
489 DIZZINESS 340 0.0007
490 EMOTIONAL DISORDER 21 0.0007
491 INFLUENZA LIKE ILLNESS 56 0.0007
492 LYMPHOCYTE COUNT DECREASED 12 0.0007
493 ANXIETY 193 0.0007
494 HEAD DISCOMFORT 12 0.0007
495 EAR INFECTION 18 0.0007
496 ARTHROPOD BITE 5 0.0007
497 TRANSAMINASES INCREASED 15 0.0007
498 ATAXIA 8 0.0007
499 ASTHMA 76 0.0007
500 FLUSHING 68 0.0007
501 DRUG EFFECT DECREASED 36 0.0007
502 BLOOD PRESSURE INCREASED 102 0.0007
503 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
504 TOOTHACHE 12 0.0007
505 TENDON PAIN 5 0.0007
506 BONE DISORDER 12 0.0007
507 TROPONIN INCREASED 5 0.0007
508 HAEMODYNAMIC INSTABILITY 5 0.0007
509 DRUG DISPENSING ERROR 10 0.0007
510 DECREASED ACTIVITY 7 0.0006
511 CONVULSION 37 0.0006
512 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 46 0.0006
513 ANKLE FRACTURE 10 0.0006
514 APHONIA 9 0.0006
515 WEIGHT DECREASED 180 0.0006
516 CYST 8 0.0006
517 MASS 9 0.0006
518 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
519 PSYCHOTIC DISORDER 19 0.0006
520 APPENDICITIS 6 0.0006
521 HAEMORRHAGIC STROKE 5 0.0006
522 FLANK PAIN 6 0.0006
523 OFF LABEL USE 560 0.0006
524 FEELING JITTERY 12 0.0006
525 HALLUCINATION, AUDITORY 10 0.0006
526 INTENTIONAL PRODUCT USE ISSUE 55 0.0006
527 MULTIPLE SCLEROSIS 30 0.0006
528 SCIATICA 10 0.0006
529 CARDIOGENIC SHOCK 9 0.0006
530 ABSCESS 10 0.0006
531 FATIGUE 487 0.0006
532 MYDRIASIS 8 0.0006
533 ABDOMINAL DISTENSION 65 0.0006
534 HYPOKINESIA 9 0.0006
535 LIVER FUNCTION TEST ABNORMAL 18 0.0006
536 HAEMATOMA 16 0.0006
537 MUSCLE DISORDER 5 0.0006
538 HALLUCINATION, VISUAL 13 0.0006
539 AMNESIA 40 0.0006
540 MICTURITION URGENCY 7 0.0006
541 NERVOUSNESS 32 0.0006
542 BODY TEMPERATURE DECREASED 6 0.0006
543 JOINT INJURY 13 0.0006
544 GASTRIC HAEMORRHAGE 7 0.0006
545 URINARY INCONTINENCE 18 0.0006
546 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
547 DYSGEUSIA 45 0.0006
548 DISORIENTATION 24 0.0006
549 CRYING 22 0.0006
550 RESPIRATORY DISORDER 18 0.0006
551 INJECTION SITE BRUISING 48 0.0006
552 POST PROCEDURAL HAEMORRHAGE 7 0.0006
553 BACK PAIN 139 0.0006
554 HEART RATE DECREASED 21 0.0006
555 ABDOMINAL PAIN UPPER 123 0.0006
556 CYSTITIS 19 0.0006
557 ABDOMINAL DISCOMFORT 100 0.0006
558 WITHDRAWAL SYNDROME 25 0.0006
559 METABOLIC ACIDOSIS 19 0.0006
560 ARTHRALGIA 247 0.0006
561 ANGINA PECTORIS 17 0.0006
562 SUBARACHNOID HAEMORRHAGE 6 0.0006
563 ACCIDENT 7 0.0006
564 THYROID DISORDER 9 0.0006
565 SKIN LESION 16 0.0006
566 VISION BLURRED 80 0.0006
567 MEMORY IMPAIRMENT 80 0.0006
568 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
569 RHEUMATOID ARTHRITIS 66 0.0006
570 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
571 PSYCHOLOGICAL TRAUMA 5 0.0006
572 DRUG INEFFECTIVE 762 0.0006
573 ASTHENIA 217 0.0006
574 NOCTURIA 7 0.0006
575 ILL-DEFINED DISORDER 35 0.0006
576 POLLAKIURIA 24 0.0006
577 EPISTAXIS 43 0.0006
578 HERPES ZOSTER 33 0.0006
579 INFLUENZA 64 0.0006
580 SEDATION 15 0.0006
581 OROPHARYNGEAL PAIN 53 0.0006
582 URINE OUTPUT DECREASED 5 0.0006
583 CARPAL TUNNEL SYNDROME 8 0.0006
584 INJECTION SITE DISCOMFORT 6 0.0006
585 URINARY RETENTION 19 0.0006
586 WEIGHT INCREASED 127 0.0006
587 TENDON RUPTURE 7 0.0006
588 SLEEP DISORDER 40 0.0006
589 PSORIATIC ARTHROPATHY 23 0.0006
590 RESPIRATORY TRACT CONGESTION 9 0.0006
591 SKIN DISCOLOURATION 26 0.0006
592 ULCER 9 0.0006
593 GENERALISED OEDEMA 7 0.0006
594 OBESITY 9 0.0006
595 VISUAL IMPAIRMENT 70 0.0006
596 PHARYNGITIS 7 0.0006
597 GAIT DISTURBANCE 108 0.0006
598 RETCHING 12 0.0006
599 LOSS OF CONSCIOUSNESS 72 0.0006
600 GASTROINTESTINAL INFECTION 5 0.0006
601 EPILEPSY 17 0.0006
602 HEAVY MENSTRUAL BLEEDING 5 0.0006
603 PHARYNGITIS STREPTOCOCCAL 6 0.0006
604 OROPHARYNGEAL DISCOMFORT 5 0.0006
605 LUNG DISORDER 27 0.0006
606 ALOPECIA 108 0.0005
607 NIGHTMARE 19 0.0005
608 DYSPEPSIA 54 0.0005
609 HIDRADENITIS 5 0.0005
610 INTRAOCULAR PRESSURE INCREASED 7 0.0005
611 EXOSTOSIS 5 0.0005
612 ABDOMINAL PAIN 127 0.0005
613 DRUG RESISTANCE 14 0.0005
614 HALLUCINATION 41 0.0005
615 RETINAL DETACHMENT 5 0.0005
616 DYSURIA 20 0.0005
617 INFUSION RELATED REACTION 36 0.0005
618 ACUTE MYOCARDIAL INFARCTION 16 0.0005
619 BLOOD PRESSURE FLUCTUATION 13 0.0005
620 AGRANULOCYTOSIS 10 0.0005
621 HEAD INJURY 17 0.0005
622 MALNUTRITION 6 0.0005
623 RASH PAPULAR 12 0.0005
624 DIARRHOEA HAEMORRHAGIC 5 0.0005
625 OSTEOPOROSIS 22 0.0005
626 TYPE 2 DIABETES MELLITUS 18 0.0005
627 LACERATION 5 0.0005
628 COUGH 149 0.0005
629 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
630 HYPOAESTHESIA ORAL 8 0.0005
631 MENTAL DISORDER 23 0.0005
632 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
633 ACIDOSIS 4 0.0005
634 INSURANCE ISSUE 8 0.0005
635 QUALITY OF LIFE DECREASED 7 0.0005
636 UPPER RESPIRATORY TRACT INFECTION 24 0.0005
637 GLAUCOMA 10 0.0005
638 COVID-19 91 0.0005
639 SINUS BRADYCARDIA 5 0.0005
640 DYSPNOEA 291 0.0005
641 HAEMORRHOIDS 10 0.0005
642 PAIN IN EXTREMITY 151 0.0005
643 VIRAL INFECTION 17 0.0005
644 COLD SWEAT 9 0.0005
645 BLOOD PRESSURE ABNORMAL 10 0.0005
646 COORDINATION ABNORMAL 7 0.0005
647 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
648 PREGNANCY 10 0.0005
649 URINARY TRACT INFECTION 85 0.0005
650 SKIN REACTION 7 0.0005
651 LACRIMATION INCREASED 15 0.0005
652 BLINDNESS UNILATERAL 7 0.0005
653 MULTIPLE SCLEROSIS RELAPSE 34 0.0005
654 PRODUCT PHYSICAL ISSUE 10 0.0005
655 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
656 MENTAL IMPAIRMENT 12 0.0005
657 STEVENS-JOHNSON SYNDROME 11 0.0005
658 BURSITIS 6 0.0005
659 PERIPHERAL SWELLING 76 0.0005
660 NO THERAPEUTIC RESPONSE 6 0.0005
661 MOTOR DYSFUNCTION 5 0.0005
662 RECTAL HAEMORRHAGE 21 0.0005
663 ABNORMAL FAECES 4 0.0005
664 LETHARGY 28 0.0005
665 RIB FRACTURE 10 0.0005
666 STAPHYLOCOCCAL INFECTION 16 0.0005
667 HYPERTHYROIDISM 7 0.0005
668 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
669 MATERNAL EXPOSURE DURING PREGNANCY 43 0.0005
670 DECREASED APPETITE 112 0.0005
671 TOOTH EXTRACTION 6 0.0005
672 GASTROENTERITIS 7 0.0005
673 SECRETION DISCHARGE 6 0.0005
674 CEREBROVASCULAR ACCIDENT 81 0.0005
675 FACE OEDEMA 8 0.0005
676 MUSCLE ATROPHY 6 0.0005
677 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
678 RENAL FAILURE ACUTE 20 0.0005
679 ABNORMAL DREAMS 13 0.0005
680 CONFUSIONAL STATE 76 0.0005
681 PULMONARY MASS 7 0.0005
682 INJECTION SITE SWELLING 36 0.0005
683 EATING DISORDER 10 0.0005
684 PULMONARY FIBROSIS 9 0.0005
685 BREAST PAIN 5 0.0005
686 C-REACTIVE PROTEIN INCREASED 17 0.0005
687 ROTATOR CUFF SYNDROME 6 0.0005
688 HEREDITARY ANGIOEDEMA 5 0.0005
689 IRRITABILITY 28 0.0005
690 ECONOMIC PROBLEM 7 0.0005
691 BREAST CANCER 43 0.0005
692 MENSTRUATION DELAYED 5 0.0005
693 SURGERY 27 0.0005
694 SEIZURE 53 0.0005
695 ASPIRATION 5 0.0005
696 IMMUNE SYSTEM DISORDER 6 0.0005
697 PULMONARY CONGESTION 6 0.0005
698 HYPERSOMNIA 13 0.0005
699 EXPIRED PRODUCT ADMINISTERED 15 0.0005
700 FOOT DEFORMITY 5 0.0005
701 DEHYDRATION 60 0.0004
702 SKIN DISORDER 15 0.0004
703 HYPERTENSIVE CRISIS 5 0.0004
704 BREAST CANCER FEMALE 12 0.0004
705 HAIR TEXTURE ABNORMAL 6 0.0004
706 MENSTRUATION IRREGULAR 12 0.0004
707 BRAIN FOG 7 0.0004
708 ILLNESS 46 0.0004
709 MOBILITY DECREASED 32 0.0004
710 FEEDING DISORDER 9 0.0004
711 SYNOVITIS 8 0.0004
712 EYE PAIN 25 0.0004
713 LEUKOCYTOSIS 8 0.0004
714 LIMB INJURY 12 0.0004
715 FALL 147 0.0004
716 PNEUMOTHORAX 7 0.0004
717 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
718 SWELLING 41 0.0004
719 GASTRIC DISORDER 15 0.0004
720 MOVEMENT DISORDER 14 0.0004
721 INJECTION SITE REACTION 30 0.0004
722 BLOOD POTASSIUM DECREASED 13 0.0004
723 LACTIC ACIDOSIS 14 0.0004
724 ARTHRITIS 34 0.0004
725 MUSCLE SPASMS 79 0.0004
726 HEPATIC STEATOSIS 8 0.0004
727 CONTUSION 41 0.0004
728 SKIN ULCER 11 0.0004
729 RASH PRURITIC 23 0.0004
730 PRURITUS 163 0.0004
731 BLOOD IRON DECREASED 5 0.0004
732 FUNGAL INFECTION 14 0.0004
733 APPLICATION SITE ERYTHEMA 11 0.0004
734 PRODUCT QUALITY ISSUE 57 0.0004
735 SUBDURAL HAEMATOMA 6 0.0004
736 INJECTION SITE PRURITUS 28 0.0004
737 PRURITUS GENERALISED 9 0.0004
738 THYROID CANCER 5 0.0004
739 VAGINAL HAEMORRHAGE 18 0.0004
740 INJECTION SITE HAEMATOMA 6 0.0004
741 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
742 APATHY 6 0.0004
743 PYREXIA 142 0.0004
744 AGITATION 30 0.0004
745 KIDNEY INFECTION 8 0.0004
746 INJECTION SITE URTICARIA 10 0.0004
747 MENORRHAGIA 8 0.0004
748 BLOOD PRESSURE DECREASED 27 0.0004
749 INJECTION SITE EXTRAVASATION 5 0.0004
750 WHEEZING 24 0.0004
751 TOXICITY TO VARIOUS AGENTS 68 0.0004
752 ORAL PAIN 9 0.0004
753 LOCAL SWELLING 7 0.0004
754 HAEMORRHAGE INTRACRANIAL 6 0.0004
755 PANCREATITIS ACUTE 9 0.0004
756 DIVERTICULITIS 11 0.0004
757 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
758 BRADYCARDIA 21 0.0004
759 ARTHROPATHY 22 0.0004
760 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
761 DIARRHOEA 253 0.0004
762 CEREBRAL HAEMORRHAGE 14 0.0004
763 GASTROINTESTINAL DISORDER 35 0.0004
764 INJECTION SITE HAEMORRHAGE 31 0.0004
765 GASTROENTERITIS VIRAL 7 0.0004
766 MUSCULOSKELETAL CHEST PAIN 6 0.0004
767 TENDONITIS 6 0.0004
768 CATARACT 23 0.0004
769 EJECTION FRACTION DECREASED 6 0.0004
770 DRUG EFFECT INCOMPLETE 14 0.0004
771 RED BLOOD CELL COUNT DECREASED 11 0.0004
772 PULMONARY HYPERTENSION 8 0.0004
773 ANAEMIA 73 0.0004
774 CHRONIC KIDNEY DISEASE 29 0.0004
775 CYANOSIS 6 0.0004
776 ARRHYTHMIA 18 0.0004
777 ORAL CANDIDIASIS 5 0.0004
778 HAEMATURIA 13 0.0004
779 PRODUCT PRESCRIBING ERROR 9 0.0004
780 MEDICATION ERROR 21 0.0004
781 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
782 RASH MACULAR 13 0.0004
783 BLINDNESS 15 0.0004
784 TACHYPNOEA 5 0.0004
785 ADVERSE DRUG REACTION 33 0.0004
786 DIABETES MELLITUS 28 0.0004
787 CHILLS 43 0.0004
788 HEPATIC ENZYME INCREASED 25 0.0004
789 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
790 POST PROCEDURAL COMPLICATION 7 0.0004
791 DRUG PRESCRIBING ERROR 7 0.0004
792 ABASIA 9 0.0004
793 VENTRICULAR TACHYCARDIA 6 0.0004
794 APPLICATION SITE PAIN 8 0.0004
795 SUICIDE ATTEMPT 22 0.0004
796 MUSCULOSKELETAL PAIN 19 0.0004
797 TREATMENT FAILURE 30 0.0004
798 HERNIA 7 0.0004
799 PRESCRIBED OVERDOSE 7 0.0004
800 PROCEDURAL PAIN 10 0.0004
801 TOOTH DISORDER 8 0.0004
802 PANCREATITIS 19 0.0004
803 INTENTIONAL OVERDOSE 23 0.0004
804 UNEVALUABLE EVENT 27 0.0004
805 ABDOMINAL PAIN LOWER 9 0.0004
806 ACCIDENTAL OVERDOSE 13 0.0004
807 ANGER 12 0.0004
808 CARDIOVASCULAR DISORDER 9 0.0004
809 INTENTIONAL DOSE OMISSION 10 0.0004
810 OEDEMA 19 0.0003
811 CONDITION AGGRAVATED 106 0.0003
812 HEPATIC FUNCTION ABNORMAL 13 0.0003
813 EMOTIONAL DISTRESS 42 0.0003
814 OEDEMA PERIPHERAL 42 0.0003
815 DYSSTASIA 10 0.0003
816 PRODUCT USE ISSUE 64 0.0003
817 CARDIOMYOPATHY 5 0.0003
818 EXPOSURE DURING PREGNANCY 21 0.0003
819 CELLULITIS 17 0.0003
820 HYPONATRAEMIA 19 0.0003
821 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
822 ADVERSE EVENT 31 0.0003
823 PAIN OF SKIN 9 0.0003
824 FREQUENT BOWEL MOVEMENTS 9 0.0003
825 INJECTION SITE PAIN 102 0.0003
826 OSTEOMYELITIS 6 0.0003
827 ADRENAL INSUFFICIENCY 4 0.0003
828 DEVICE FAILURE 5 0.0003
829 HAEMATOCHEZIA 18 0.0003
830 ERYTHEMA 67 0.0003
831 INJECTION SITE RASH 10 0.0003
832 INJECTION SITE MASS 12 0.0003
833 MENTAL STATUS CHANGES 9 0.0003
834 FEMUR FRACTURE 10 0.0003
835 BASAL CELL CARCINOMA 5 0.0003
836 DRUG WITHDRAWAL SYNDROME 28 0.0003
837 BLOOD SODIUM DECREASED 6 0.0003
838 NEUROPATHY PERIPHERAL 30 0.0003
839 RASH 137 0.0003
840 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
841 PLEURAL EFFUSION 19 0.0003
842 ERECTILE DYSFUNCTION 8 0.0003
843 DYSTONIA 6 0.0003
844 BACK DISORDER 5 0.0003
845 HAEMATOCRIT DECREASED 6 0.0003
846 HYPERGLYCAEMIA 11 0.0003
847 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
848 UPPER LIMB FRACTURE 6 0.0003
849 FLATULENCE 17 0.0003
850 ATRIAL FIBRILLATION 29 0.0003
851 INFECTION 43 0.0003
852 INTENTIONAL SELF-INJURY 6 0.0003
853 EYE SWELLING 11 0.0003
854 INJURY ASSOCIATED WITH DEVICE 6 0.0003
855 MYOCARDIAL INFARCTION 51 0.0003
856 INTESTINAL OBSTRUCTION 11 0.0003
857 BONE PAIN 17 0.0003
858 INJECTION SITE ERYTHEMA 36 0.0003
859 COLITIS 11 0.0003
860 TOOTH LOSS 6 0.0003
861 UNDERDOSE 21 0.0003
862 BONE DENSITY DECREASED 9 0.0003
863 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
864 ENCEPHALOPATHY 7 0.0003
865 DRY SKIN 38 0.0003
866 OVERDOSE 61 0.0003
867 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
868 CARDIAC DISORDER 26 0.0003
869 COMPLICATION OF DEVICE REMOVAL 5 0.0003
870 HYPOPHAGIA 7 0.0003
871 COMA 13 0.0003
872 THERAPY CESSATION 14 0.0003
873 INCORRECT DOSE ADMINISTERED 62 0.0003
874 UNRESPONSIVE TO STIMULI 7 0.0003
875 RASH GENERALISED 7 0.0003
876 COLITIS ULCERATIVE 12 0.0003
877 PULMONARY OEDEMA 12 0.0003
878 EYE PRURITUS 9 0.0003
879 ECZEMA 14 0.0003
880 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
881 THERAPY NON-RESPONDER 12 0.0003
882 OXYGEN SATURATION DECREASED 15 0.0003
883 PREMATURE BABY 8 0.0003
884 PRODUCT AVAILABILITY ISSUE 6 0.0003
885 SHOCK 6 0.0003
886 EYE IRRITATION 15 0.0003
887 PNEUMONIA 84 0.0003
888 PALLOR 7 0.0003
889 DEVICE MALFUNCTION 18 0.0003
890 ACUTE KIDNEY INJURY 39 0.0003
891 ACCIDENTAL EXPOSURE TO PRODUCT 26 0.0003
892 WOUND 7 0.0003
893 SPINAL FRACTURE 5 0.0002
894 BLISTER 14 0.0002
895 LOCALISED INFECTION 6 0.0002
896 TASTE DISORDER 5 0.0002
897 DYSKINESIA 10 0.0002
898 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
899 CARDIAC ARREST 20 0.0002
900 AGGRESSION 12 0.0002
901 DERMATITIS 5 0.0002
902 KNEE ARTHROPLASTY 5 0.0002
903 LABORATORY TEST ABNORMAL 7 0.0002
904 RENAL DISORDER 11 0.0002
905 INFLAMMATION 12 0.0002
906 THROMBOCYTOPENIA 26 0.0002
907 HEPATIC FAILURE 7 0.0002
908 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
909 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
910 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
911 HAEMORRHAGE 24 0.0002
912 PRODUCT PRESCRIBING ISSUE 5 0.0002
913 AMENORRHOEA 4 0.0002
914 DRUG ADMINISTRATION ERROR 7 0.0002
915 ABNORMAL BEHAVIOUR 9 0.0002
916 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 46 0.0002
917 RASH MACULO-PAPULAR 5 0.0002
918 NEOPLASM MALIGNANT 15 0.0002
919 PRODUCT DOSE OMISSION ISSUE 66 0.0002
920 DRUG-INDUCED LIVER INJURY 7 0.0002
921 PSORIASIS 29 0.0002
922 CHROMATURIA 5 0.0002
923 RESTLESSNESS 8 0.0002
924 DRUG DEPENDENCE 35 0.0002
925 RESPIRATORY ARREST 6 0.0002
926 HIP FRACTURE 7 0.0002
927 RESPIRATORY DISTRESS 6 0.0002
928 ACNE 16 0.0002
929 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
930 RENAL FAILURE 27 0.0002
931 DELIRIUM 7 0.0002
932 LEUKOPENIA 10 0.0002
933 PRODUCT COMPLAINT 5 0.0002
934 PRODUCT ADHESION ISSUE 7 0.0002
935 THERAPY INTERRUPTED 14 0.0002
936 HAEMOGLOBIN DECREASED 20 0.0002
937 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
938 EXPOSURE VIA SKIN CONTACT 5 0.0002
939 INCORRECT DOSE ADMINISTERED BY DEVICE 5 0.0002
940 DISEASE RECURRENCE 9 0.0002
941 CARDIAC FAILURE 15 0.0002
942 HYPOACUSIS 8 0.0002
943 HYPOGLYCAEMIA 9 0.0002
944 PNEUMONITIS 5 0.0002
945 IMPAIRED HEALING 6 0.0002
946 FEBRILE NEUTROPENIA 12 0.0002
947 SEPSIS 20 0.0002
948 HAEMOPTYSIS 5 0.0002
949 PANCYTOPENIA 10 0.0002
950 DEVICE ISSUE 16 0.0002
951 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
952 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
953 SKIN IRRITATION 8 0.0002
954 NEEDLE ISSUE 5 0.0002
955 OCULAR HYPERAEMIA 8 0.0002
956 RENAL INJURY 5 0.0002
957 SKIN BURNING SENSATION 12 0.0002
958 RENAL IMPAIRMENT 14 0.0002
959 CORONARY ARTERY DISEASE 5 0.0002
960 STOMATITIS 10 0.0002
961 RESPIRATORY FAILURE 12 0.0002
962 AGEUSIA 4 0.0002
963 LIVER DISORDER 7 0.0002
964 HOSPITALISATION 24 0.0002
965 NEUTROPENIA 21 0.0002
966 SKIN EXFOLIATION 13 0.0002
967 PLASMA CELL MYELOMA 6 0.0002
968 DERMATITIS ATOPIC 8 0.0002
969 DEVICE DIFFICULT TO USE 10 0.0002
970 GAIT INABILITY 5 0.0001
971 DEPENDENCE 8 0.0001
972 BLOOD GLUCOSE INCREASED 26 0.0001
973 SEPTIC SHOCK 6 0.0001
974 BLOOD CREATININE INCREASED 9 0.0001
975 FLUID RETENTION 7 0.0001
976 PLATELET COUNT DECREASED 14 0.0001
977 PRODUCT STORAGE ERROR 11 0.0001
978 EXTRA DOSE ADMINISTERED 5 0.0001
979 DEVICE BREAKAGE 5 0.0001
980 RHABDOMYOLYSIS 5 0.0001
981 CARDIO-RESPIRATORY ARREST 5 0.0001
982 DEVICE LEAKAGE 5 0.0001
983 DEVICE DISLOCATION 5 0.0001
984 TREATMENT NONCOMPLIANCE 6 0.0001
985 DEATH 87 0.0001
986 CARDIAC FAILURE CONGESTIVE 8 0.0001
987 PROSTATE CANCER 6 0.0001
988 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
989 COMPLETED SUICIDE 5 0.0001
990 DISEASE PROGRESSION 7 0.0001
991 NO ADVERSE EVENT 10 0.0001